No Data
No Data
Express News | Scynexis Inc - Cash Runway Exceeds Two Years
Express News | Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications
Express News | Scynexis Inc - Milestone Payment Triggered by Clinical Study Reports
Express News | Scynexis : Eligible for Additional $323 Million in Milestone Payments
Express News | Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports
Buy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal Pipeline
No Data
TrytosaveabitOP : Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications